Kinimmune, Inc.
St. Louis, MO
- UEI
- S26QVFQMACK7
- CAGE
- 8RM45
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 341 Conway Hill Rd, St. Louis, MO 63141, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Development of a tumor-retentive immunostimulant as adjunct therapy for solid tumor cancers | National Cancer Institute (NIH) | $777,052 |
Quick answers
Is Kinimmune, Inc. registered in SAM.gov?
Yes. Kinimmune, Inc.'s SAM.gov registration is active through February 23, 2027.
What is Kinimmune, Inc.'s most recent federal award?
Kinimmune, Inc.'s most recent federal grant award is Development of a tumor-retentive immunostimulant as adjunct therapy for solid tumor cancers (R41CA272024), from National Cancer Institute (NIH), on September 7, 2022.
On GovTribe
See Kinimmune, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors